Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Prendergast

Showing results (21-30 of 247) with videos related to

Pageof 25
Sort By:
Histology and Histopathology|December 6, 2005
RhoB in cancer suppressionM Huang, G C Prendergast
Expert Opinion on Investigational Drugs|January 5, 2002
Farnesyltransferase inhibitors: mechanism and applicationsG C Prendergast, N Rane
Cell Cycle (Georgetown, Tex.)|July 6, 2007
Bin1 homolog hob1 supports a Rad6-Set1 pathway of transcriptional repression in fission yeastArivudainambi Ramalingam, George C Prendergast
Seminars in Cancer Biology|February 15, 2001
Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospectsG C Prendergast, A Oliff
Genomics|July 25, 2000
Bin2, a functionally nonredundant member of the BAR adaptor gene familyK Ge, G C Prendergast
FEBS Letters|September 29, 2000
Geranylgeranylated RhoB is sufficient to mediate tissue-specific suppression of Akt kinase activity by farnesyltransferase inhibitorsA Liu, G C Prendergast
Cancer Biology & Therapy|May 7, 2005
Genetic response to DNA damage: proapoptotic targets of RhoB include modules for p53 response and susceptibility to Alzheimer's diseaseUma Kamasani, George C Prendergast
Oncotarget|February 4, 2016
Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancerJames DuHadaway, George C Prendergast
Frontiers in Pharmacology|July 31, 2023
Gut-brain connections in neurodegenerative disease: immunotherapeutic targeting of Bin1 in inflammatory bowel disease and Alzheimer's diseaseSunil Thomas, George C Prendergast
Cancer Research|December 20, 1999
Geranylgeranylated RhoB mediates suppression of human tumor cell growth by farnesyltransferase inhibitorsW Du, G C Prendergast
Pageof 25

Showing results (21-30 of 247) with videos related to

Sort By:
Pageof 25
Histology and Histopathology|December 6, 2005
RhoB in cancer suppressionM Huang, G C Prendergast
Expert Opinion on Investigational Drugs|January 5, 2002
Farnesyltransferase inhibitors: mechanism and applicationsG C Prendergast, N Rane
Cell Cycle (Georgetown, Tex.)|July 6, 2007
Bin1 homolog hob1 supports a Rad6-Set1 pathway of transcriptional repression in fission yeastArivudainambi Ramalingam, George C Prendergast
Seminars in Cancer Biology|February 15, 2001
Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospectsG C Prendergast, A Oliff
Genomics|July 25, 2000
Bin2, a functionally nonredundant member of the BAR adaptor gene familyK Ge, G C Prendergast
FEBS Letters|September 29, 2000
Geranylgeranylated RhoB is sufficient to mediate tissue-specific suppression of Akt kinase activity by farnesyltransferase inhibitorsA Liu, G C Prendergast
Cancer Biology & Therapy|May 7, 2005
Genetic response to DNA damage: proapoptotic targets of RhoB include modules for p53 response and susceptibility to Alzheimer's diseaseUma Kamasani, George C Prendergast
Oncotarget|February 4, 2016
Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancerJames DuHadaway, George C Prendergast
Frontiers in Pharmacology|July 31, 2023
Gut-brain connections in neurodegenerative disease: immunotherapeutic targeting of Bin1 in inflammatory bowel disease and Alzheimer's diseaseSunil Thomas, George C Prendergast
Cancer Research|December 20, 1999
Geranylgeranylated RhoB mediates suppression of human tumor cell growth by farnesyltransferase inhibitorsW Du, G C Prendergast
Pageof 25